Handelsbanken Fonder’s Kymera Therapeutics KYMR Stock Holding History

Handelsbanken Fonder’s Portfolio KYMR Stock Details KYMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.37M	Buy	20,700 +2,700	+15%	+$232K	0.01%	753
2026 Q1	$1.5M	Hold	18,000	–	–	0.01%	859
2025 Q4	$1.4M	Sell	18,000 -3,700	-17%	-$250K	﹤0.01%	893
2025 Q3	$1.23M	Buy	21,700 +5,200	+32%	+$235K	﹤0.01%	925
2025 Q2	$720K	Hold	16,500	–	–	﹤0.01%	1093
2025 Q1	$452K	Hold	16,500	–	–	﹤0.01%	1270
2024 Q4	$664K	Sell	16,500 -800	-5%	-$36.1K	﹤0.01%	1175
2024 Q3	$819K	Buy	17,300 +1,900	+12%	+$83.9K	﹤0.01%	1024
2024 Q2	$460K	Buy	+15,400	New	+$533K	﹤0.01%	1194
2023 Q4	–	Sell	-10,600	Closed	-$147K	–	1579
2023 Q3	$147K	Hold	10,600	–	–	﹤0.01%	1514
2023 Q2	$244K	Sell	10,600 -5,300	-33%	-$152K	﹤0.01%	1429
2023 Q1	$471K	Hold	15,900	–	–	﹤0.01%	1026
2022 Q4	$397K	Buy	+15,900	New	+$424K	﹤0.01%	1084
2022 Q2	–	Sell	-7,700	Closed	-$326K	–	1660
2022 Q1	$326K	Hold	7,700	–	–	﹤0.01%	1472
2021 Q4	$489K	Sell	7,700 -1,100	-13%	-$64.1K	﹤0.01%	1365
2021 Q3	$517K	Hold	8,800	–	–	﹤0.01%	1345
2021 Q2	$427K	Buy	+8,800	New	+$382K	﹤0.01%	1489

Other funds holding KYMR

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Handelsbanken Fonder's KYMR Position: Q2 2026 in Review

Handelsbanken Fonder increased its Kymera Therapeutics (KYMR) stake by 15% in Q2 2026, buying an estimated $232K and bringing the position to 20,700 shares worth $2.37M. The position accounts for 0.01% of the portfolio, ranked #753.

Handelsbanken Fonder first reported a position in KYMR in Q2 2021 and has held it in 17 quarters since. 81 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

Handelsbanken Fonder held 20,700 shares of Kymera Therapeutics worth $2.37M as of Q2 2026.
Handelsbanken Fonder bought 2,700 Kymera Therapeutics shares in Q2 2026, an estimated $232K.
Kymera Therapeutics made up 0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #753 holding.
Handelsbanken Fonder first reported a position in Kymera Therapeutics in Q2 2021 and has held it in 17 quarters since.
81 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.